SU-E-T-224: Dose Distribution of Oesophagus Stents Measured by EBT2 Film Dosimetry

2012 ◽  
Vol 39 (6Part13) ◽  
pp. 3755-3755
Author(s):  
D Poppinga ◽  
A Schoenfeld ◽  
N Chofor ◽  
B Poppe
2017 ◽  
Vol 51 (4) ◽  
pp. 469-474 ◽  
Author(s):  
Grzegorz Zwierzchowski ◽  
Grzegorz Bieleda ◽  
Janusz Skowronek

Abstract Background Fast and easily repeatable methods for commissioning procedures for brachytherapy (BT) treatment planning systems (TPS) are needed. Radiochromic film dosimetry with gamma analysis is widely used in external beam quality assurance (QA) procedures and planar film dosimetry is also increasingly used for verification of the dose distribution in BT applications. Using the gamma analysis method for comparing calculated and measured dose data could be used for commissioning procedures of the newly developed TG-186 and MBDCA calculation algorithms. The aim of this study was dosimetric verification of the calculation algorithm used in TPS when the CT/MRI ring applicator is used. Materials and methods Ring applicators with 26 and 30 mm diameters and a 60 mm intra-uterine tube with 60° angle were used for verification. Gafchromic® EBT films were used as dosimetric media. Dose grids, corresponding to each plane (dosimetric film location), were exported from the TPS as a raw data. Gafchromic® films were digitized after irradiation. gamma analysis of the data were performed using the OMNI Pro I’mRT® system, as recommended by the AAPM TG-119 rapport criterion for gamma analysis of 3%, 3 mm and a level of 95%. Results For the 26 mm and 30 mm rings, the average gamma ranged, respectively, from 0.1 to 0.44 and from 0.1 to 0.27. In both cases, 99% of the measured points corresponded with the calculated data. Conclusions This analysis showed excellent agreement between the dose distribution calculated with the TPS and the doses measured by Gafchromic films. This finding confirms the viability of using film dosimetry in BT.


2013 ◽  
Vol 106 ◽  
pp. S296
Author(s):  
N. Corradini ◽  
K. Schombourg ◽  
S. Presilla ◽  
G. Ballerini ◽  
A. Franzetti-Pellanda

2018 ◽  
Vol 17 (4) ◽  
pp. 403-410 ◽  
Author(s):  
Khalid Iqbal ◽  
Geoffrey S. Ibbott ◽  
Ryan G. Lafratta ◽  
Kent A. Gifford ◽  
Muhammad Akram ◽  
...  

AbstractPurposeTo determine the feasibility of an anthropomorphic breast polyurethane-based three-dimensional (3D) dosimeter with cavity to measure dose distributions and skin dose for a commercial strut-based applicator strut-adjusted volume implant (SAVI™) 6–1.Materials and methodsAn anthropomorphic breast 3D dosimeter was created with a cavity to accommodate the SAVI™ strut-based device. 2 Gy was prescribed to the breast dosimeter having D95 to planning target volume evaluation (PTV_EVAL) while limiting 125% of the prescribed dose to the skin. Independent dose distribution verification was performed with GAFCHROMIC® EBT2 film. The dose distribution from the 3D dosimeter was compared to the distributions from commercial brachytherapy treatment planning system (TPS) and film. Point skin doses, line profiles and dose–volume histogram (DVHs) for the skin and PTV_EVAL were compared.ResultsThe maximum difference in skin dose for TPS and the 3D dosimeter was 4% whereas 41% between the TPS and EBT2 film. The maximum dose difference for line profiles between TPS, 3D dosimeter, and film was 4·1%. DVHs of skin and PTV_EVAL for TPS and 3D dosimeter differed by a maximum of 4% at 5 mm depth and skin differed by a maximum 1·5% between TPS and 3D dosimeter. The criterion for gamma analysis comparison was 92·5% at ±5%±3 mm criterion. The TPS demonstrated at least ±5% comparability in predicting dose to the skin, PTV_EVAL and normal breast tissue.Conclusions3D anthropomorphic polyurethane dosimeter with cavity gives comparable results to the TPS dose predictions and GAFCHROMIC® EBT2 film results in the context of HDR brachytherapy.


2013 ◽  
Vol 62 (4) ◽  
pp. 657-663 ◽  
Author(s):  
Sung Hyun Lee ◽  
Kum Bae Kim ◽  
Mi-Sook Kim ◽  
Hyung-Jun Yoo ◽  
Seungwoo Park ◽  
...  

2012 ◽  
Vol 151 (2) ◽  
pp. 272-277 ◽  
Author(s):  
J. Kim ◽  
M. Yoon ◽  
S. Kim ◽  
D. Shin ◽  
S. B. Lee ◽  
...  

2010 ◽  
Vol 37 (6Part19) ◽  
pp. 3237-3237
Author(s):  
S Ozawa ◽  
T Furuya ◽  
M Kawashima ◽  
C Kurokawa ◽  
K Karasawa ◽  
...  

2012 ◽  
Vol 39 (6Part13) ◽  
pp. 3759-3759
Author(s):  
D Poppinga ◽  
A Schoenfeld ◽  
B Poppe ◽  
N Chofor

Sign in / Sign up

Export Citation Format

Share Document